Literature DB >> 26370739

Pulmonary endarterectomy as treatment for chronic thromboembolic pulmonary hypertension in sickle cell disease.

Ashley T Freeman1, Kenneth I Ataga1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26370739      PMCID： PMC4715583          DOI： 10.1002/ajh.24192

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  7 in total

1.  Reduction of painful vaso-occlusive crisis of sickle cell anaemia by tinzaparin in a double-blind randomized trial.

Authors:  Mohamad Hasan Qari; Soad Khalil Aljaouni; Mohamad Salleh Alardawi; Huda Fatani; Fatin Mohamad Alsayes; Panagiotis Zografos; Mohamad Alsaigh; Adnan Alalfi; Mohamad Alamin; Abdulilah Gadi; Shaker A Mousa
Journal:  Thromb Haemost       Date:  2007-08       Impact factor: 5.249

2.  A role for coagulation factor Xa in experimental pulmonary arterial hypertension.

Authors:  Martina Delbeck; Katrin F Nickel; Elisabeth Perzborn; Peter Ellinghaus; Julia Strassburger; Raimund Kast; Volker Laux; Stefan Schäfer; Ralph T Schermuly; Georges von Degenfeld
Journal:  Cardiovasc Res       Date:  2011-06-15       Impact factor: 10.787

3.  An official American Thoracic Society clinical practice guideline: diagnosis, risk stratification, and management of pulmonary hypertension of sickle cell disease.

Authors:  Elizabeth S Klings; Roberto F Machado; Robyn J Barst; Claudia R Morris; Kamal K Mubarak; Victor R Gordeuk; Gregory J Kato; Kenneth I Ataga; J Simon Gibbs; Oswaldo Castro; Erika B Rosenzweig; Namita Sood; Lewis Hsu; Kevin C Wilson; Marilyn J Telen; Laura M Decastro; Lakshmanan Krishnamurti; Martin H Steinberg; David B Badesch; Mark T Gladwin
Journal:  Am J Respir Crit Care Med       Date:  2014-03-15       Impact factor: 21.405

4.  Endothelial nitric oxide synthase and nitric oxide regulate endothelial tissue factor expression in vivo in the sickle transgenic mouse.

Authors:  Anna Solovey; Rahn Kollander; Liming Chang Milbauer; Fuad Abdulla; Yingie Chen; Robert J Kelm; Robert P Hebbel
Journal:  Am J Hematol       Date:  2010-01       Impact factor: 10.047

5.  Venous thromboembolism in adults with sickle cell disease: a serious and under-recognized complication.

Authors:  Rakhi P Naik; Michael B Streiff; Carlton Haywood; Julie A Nelson; Sophie Lanzkron
Journal:  Am J Med       Date:  2013-05       Impact factor: 4.965

6.  Heme induces endothelial tissue factor expression: potential role in hemostatic activation in patients with hemolytic anemia.

Authors:  B N Y Setty; S G Betal; J Zhang; M J Stuart
Journal:  J Thromb Haemost       Date:  2008-10-01       Impact factor: 5.824

7.  Coagulation activation and inflammation in sickle cell disease-associated pulmonary hypertension.

Authors:  Kenneth I Ataga; Charity G Moore; Cheryl A Hillery; Susan Jones; Herbert C Whinna; Dell Strayhorn; Cathy Sohier; Alan Hinderliter; Leslie V Parise; Eugene P Orringer
Journal:  Haematologica       Date:  2008-01       Impact factor: 9.941
  7 in total
  4 in total

1.  Abnormal Ventilation-Perfusion Scan Is Associated with Pulmonary Hypertension in Sickle Cell Adults.

Authors:  Alem Mehari; Norris Igbineweka; Darlene Allen; Jim Nichols; Swee Lay Thein; Nargues A Weir
Journal:  J Nucl Med       Date:  2018-06-07       Impact factor: 10.057

Review 2.  Pathophysiology and treatment of pulmonary hypertension in sickle cell disease.

Authors:  Victor R Gordeuk; Oswaldo L Castro; Roberto F Machado
Journal:  Blood       Date:  2016-01-12       Impact factor: 22.113

Review 3.  Focused Update on Pulmonary Hypertension in Children-Selected Topics of Interest for the Adult Cardiologist.

Authors:  Sulaima Albinni; Manfred Marx; Irene M Lang
Journal:  Medicina (Kaunas)       Date:  2020-08-19       Impact factor: 2.430

4.  Pulmonary thromboendarterectomy in patients with chronic thromboembolic pulmonary hypertension and hemoglobinopathies.

Authors:  Ana Cecília Cardoso de Sousa; Frederico Thadeu Assis Figueiredo Campos; Rodrigo de Castro Bernardes; Marcelo Braga Ivo; Ricardo de Amorim Corrêa
Journal:  J Bras Pneumol       Date:  2020-03-27       Impact factor: 2.800
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.